These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 28483374

  • 21. 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin's and Non-Hodgkin Lymphomas.
    Withofs N, Bonnet C, Hustinx R.
    PET Clin; 2024 Oct; 19(4):447-462. PubMed ID: 38945737
    [Abstract] [Full Text] [Related]

  • 22. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 23. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
    Xiao-Xue W, Xinyue H, Lijun Z.
    Med Clin (Barc); 2020 Jan 24; 154(2):61-65. PubMed ID: 31757394
    [Abstract] [Full Text] [Related]

  • 24. PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma.
    Kobe C, Dietlein M, Hellwig D.
    Semin Nucl Med; 2018 Jan 24; 48(1):28-36. PubMed ID: 29195615
    [Abstract] [Full Text] [Related]

  • 25. Overview of early response assessment in lymphoma with FDG-PET.
    MacManus MP, Seymour JF, Hicks RJ.
    Cancer Imaging; 2007 Jan 24; 7(1):10-8. PubMed ID: 17766210
    [Abstract] [Full Text] [Related]

  • 26. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
    Atkinson W, Catana C, Abramson JS, Arabasz G, McDermott S, Catalano O, Muse V, Blake MA, Barnes J, Shelly M, Hochberg E, Rosen BR, Guimaraes AR.
    Abdom Radiol (NY); 2016 Jul 24; 41(7):1338-48. PubMed ID: 27315095
    [Abstract] [Full Text] [Related]

  • 27. PET/CT in Non-Hodgkin Lymphoma: An Update.
    Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S.
    Semin Nucl Med; 2023 May 24; 53(3):320-351. PubMed ID: 36522191
    [Abstract] [Full Text] [Related]

  • 28. PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
    Karls S, Shah H, Jacene H.
    Semin Nucl Med; 2018 Jan 24; 48(1):37-49. PubMed ID: 29195616
    [Abstract] [Full Text] [Related]

  • 29. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L.
    Radiol Med; 2016 Feb 24; 121(2):132-43. PubMed ID: 26349573
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
    Spaepen K, Mortelmans L.
    Q J Nucl Med; 2001 Sep 24; 45(3):269-73. PubMed ID: 11788819
    [Abstract] [Full Text] [Related]

  • 31. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma.
    Zanoni L, Mattana F, Calabrò D, Paccagnella A, Broccoli A, Nanni C, Fanti S.
    Eur J Radiol; 2021 Aug 24; 141():109793. PubMed ID: 34148014
    [Abstract] [Full Text] [Related]

  • 32. 18F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?
    Barrington SF, Johnson PWM.
    J Nucl Med; 2017 Oct 24; 58(10):1539-1544. PubMed ID: 28798034
    [Abstract] [Full Text] [Related]

  • 33. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
    Badr S, Kotb M, Elahmadawy MA, Moustafa H.
    Clin Nucl Med; 2018 Dec 24; 43(12):e428-e438. PubMed ID: 30358625
    [Abstract] [Full Text] [Related]

  • 34. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD.
    Radiol Clin North Am; 2008 Mar 24; 46(2):213-23, vii. PubMed ID: 18619377
    [Abstract] [Full Text] [Related]

  • 35. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D, de Wit M, Beyer W, Beese M, Lübeck M, Bücheler E, Clausen M.
    Rofo; 1998 May 24; 168(5):457-65. PubMed ID: 9617362
    [Abstract] [Full Text] [Related]

  • 36. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.
    Acta Radiol; 2017 Dec 24; 58(12):1476-1484. PubMed ID: 28382828
    [Abstract] [Full Text] [Related]

  • 37. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.
    Barrington SF, Kluge R.
    Eur J Nucl Med Mol Imaging; 2017 Aug 24; 44(Suppl 1):97-110. PubMed ID: 28411336
    [Abstract] [Full Text] [Related]

  • 38. 18F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with 18F-FDG PET/CT as the Reference Standard.
    Verhagen MV, Menezes LJ, Neriman D, Watson TA, Punwani S, Taylor SA, Shankar A, Daw S, Humphries PD.
    J Nucl Med; 2021 Nov 24; 62(11):1524-1530. PubMed ID: 33608429
    [Abstract] [Full Text] [Related]

  • 39. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.
    Radiology; 2007 Jul 24; 244(1):257-62. PubMed ID: 17581905
    [Abstract] [Full Text] [Related]

  • 40. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N, Kojima M, Hasegawa M, Oriuchi N, Matsushima T, Yokohama A, Saitoh T, Handa H, Endo K, Murakami H.
    Cancer; 2007 Aug 01; 110(3):652-9. PubMed ID: 17582800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.